Camurus AB (publ) (LON:0RD1)
London · Delayed Price · Currency is GBP · Price in SEK 687.50
+7.50 (1.10%)
Feb 6, 2026, 4:24 PM GMT
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 3.34 billion as of February 6, 2026. Its market cap has increased by 35.36% in one year.
Market Cap
3.34B
Enterprise Value
3.06B
Revenue
185.85M
Ranking
n/a
PE Ratio
54.07
Stock Price
687.50
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 129.69M to 3.34B, an increase of 2,472.84%. That is a compound annual growth rate of 37.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 3.30B | 11.36% |
| Dec 30, 2025 | 2.97B | 23.15% |
| Dec 30, 2024 | 2.41B | 3.42% |
| Dec 29, 2023 | 2.33B | 108.99% |
| Dec 30, 2022 | 1.11B | 64.59% |
| Dec 30, 2021 | 677.24M | -25.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.82B |
| GSK plc | 87.48B |
| Haleon | 35.56B |
| Smith & Nephew | 10.99B |
| Convatec Group | 4.43B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.03B |
| HUTCHMED (China) | 1.87B |